Author response for 'Increased <scp> MYBL2 </scp> expression in aggressive hormone‐sensitive prostate cancer'

MLA

null Yuki Yoshikawa, et al. Author Response for “Increased MYBL2 Expression in Aggressive Hormone‐sensitive Prostate Cancer.” July 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........26eeb6fe81730cad59f6eb4bd26a1d0f&authtype=sso&custid=ns315887.

APA

null Yuki Yoshikawa, null Konrad H. Stopsack, null Xin Victoria Wang, null Yu‐Hui Chen, null Ying Z. Mazzu, null Foster Burton, null Goutam Chakraborty, null Sai Harisha Rajanala, null Rahim Hirani, null Subhiksha Nandakumar, null Gwo‐Shu Mary Lee, null David Frank, null Elai Davicioni, null Glenn Liu, null Michael A. Carducci, null Haruhito Azuma, null Philip W. Kantoff, & null Christopher J. Sweeney. (2022). Author response for “Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer.”

Chicago

null Yuki Yoshikawa, null Konrad H. Stopsack, null Xin Victoria Wang, null Yu‐Hui Chen, null Ying Z. Mazzu, null Foster Burton, null Goutam Chakraborty, et al. 2022. “Author Response for ‘Increased MYBL2 Expression in Aggressive Hormone‐sensitive Prostate Cancer,’” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........26eeb6fe81730cad59f6eb4bd26a1d0f&authtype=sso&custid=ns315887.